S. 3799: Healthy Start Reauthorization Act of 2026

The Healthy Start Reauthorization Act of 2026 (S. 3799) is a bill introduced in the U.S. Senate on February 5, 2026, by Senator Roger Marshall, with co-sponsors Senators Kirsten Gillibrand and Tammy Baldwin. The bill aims to continue funding for the Healthy Start Initiative, a program focused on reducing disparities in maternal and infant health outcomes across the United States. Specifically, it proposes allocating $145 million annually from 2026 to 2030 to support programs that improve healthcare access and education for pregnant women and new parents, particularly in underserved communities. The Healthy Start Initiative addresses issues such as high infant mortality rates and inadequate prenatal care by providing resources and support to families in need.

Supporters of the Healthy Start Reauthorization Act of 2026 commend the bill for its commitment to addressing maternal and infant health disparities. They highlight the importance of continued funding to sustain and expand programs that have proven effective in improving health outcomes for mothers and babies, especially in underserved areas. Advocates emphasize that the proposed $145 million annual funding will enable the Healthy Start Initiative to enhance healthcare access and education, ultimately contributing to healthier communities nationwide.

Critics of the Healthy Start Reauthorization Act of 2026 express concerns about the allocation of $145 million annually, questioning whether the funds will be utilized efficiently and effectively. Some argue that without clear accountability measures and program evaluations, there is a risk of mismanagement or insufficient impact on reducing health disparities. Additionally, opponents suggest that alternative approaches or reforms may be necessary to address the root causes of maternal and infant health issues more comprehensively.

The Healthy Start Reauthorization Act of 2026, sponsored by Roger Marshall, presents a significant potential conflict of interest due to the substantial financial contributions from the health professionals sector. With $360 million in donations from health professionals, who are directly impacted by healthcare legislation, there is a clear financial incentive for the sponsor to favor policies that benefit this industry. This overlap raises concerns about whether the bill is being shaped more by the interests of major donors than by the needs of constituents. Additionally, the presence of lobbying activities from various healthcare-related organizations further complicates the landscape, suggesting that multiple entities with vested interests are seeking to influence the bill's outcomes. Voters should be aware that the financial ties between the sponsor and the health professionals could lead to legislation that prioritizes donor interests over public health needs.

These industries are both affected by this bill and among the sponsor's top donors.

Organizations that lobbied on issues related to this bill's policy area.

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Top industries funding Roger Marshall, ranked by total contributions.

Source: OpenSecrets.org (Center for Responsive Politics)